Medibank Private Ltd
ASX:MPL

Watchlist Manager
Medibank Private Ltd Logo
Medibank Private Ltd
ASX:MPL
Watchlist
Price: 3.7 AUD -1.07% Market Closed
Market Cap: 10.2B AUD
Have any thoughts about
Medibank Private Ltd?
Write Note

Intrinsic Value

The intrinsic value of one MPL stock under the Base Case scenario is 3.99 AUD. Compared to the current market price of 3.7 AUD, Medibank Private Ltd is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MPL Intrinsic Value
3.99 AUD
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medibank Private Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MPL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MPL?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Medibank Private Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Medibank Private Ltd

Provide an overview of the primary business activities
of Medibank Private Ltd.

What unique competitive advantages
does Medibank Private Ltd hold over its rivals?

What risks and challenges
does Medibank Private Ltd face in the near future?

Has there been any significant insider trading activity
in Medibank Private Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medibank Private Ltd.

Provide P/S
for Medibank Private Ltd.

Provide P/E
for Medibank Private Ltd.

Provide P/B
for Medibank Private Ltd.

Show me price targets
for Medibank Private Ltd made by professional analysts.

What are the Revenue projections
for Medibank Private Ltd?

How accurate were the past Revenue estimates
for Medibank Private Ltd?

What are the Net Income projections
for Medibank Private Ltd?

How accurate were the past Net Income estimates
for Medibank Private Ltd?

What are the EPS projections
for Medibank Private Ltd?

How accurate were the past EPS estimates
for Medibank Private Ltd?

What are the EBIT projections
for Medibank Private Ltd?

How accurate were the past EBIT estimates
for Medibank Private Ltd?

Compare the revenue forecasts
for Medibank Private Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medibank Private Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medibank Private Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medibank Private Ltd compared to its peers.

Compare the P/E ratios
of Medibank Private Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Medibank Private Ltd with its peers.

Analyze the financial leverage
of Medibank Private Ltd compared to its main competitors.

Show all profitability ratios
for Medibank Private Ltd.

Provide ROE
for Medibank Private Ltd.

Provide ROA
for Medibank Private Ltd.

Provide Net Margin
for Medibank Private Ltd.

Show all solvency ratios
for Medibank Private Ltd.

What is the historical Revenue growth
over the last 5 years for Medibank Private Ltd?

What is the historical Net Income growth
over the last 5 years for Medibank Private Ltd?

What is the current Free Cash Flow
of Medibank Private Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medibank Private Ltd.

Business Breakdown

Medibank Private Ltd., founded in 1976, has established itself as one of Australia’s leading health insurance providers, servicing millions of customers with a commitment to proactive healthcare and comprehensive policies. Initially created as a government initiative to offer affordable health coverage, the company transitioned to a publicly-listed entity in 2014. Medibank operates through two main divisions: Medibank for health insurance and ahm, which primarily targets budget-conscious consumers seeking value-driven options. The firm prides itself on its customer-centric approach, focusing on empowering members through digital health solutions and preventative care initiatives that emphasi...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medibank Private Ltd

Cash & Short-Term Investments 691m
Insurance Receivable 39.5m
PP&E 205m
Long-Term Investments 3.1B
Other Assets 643m
Insurance Policy Liabilities 1.8B
Short Term Debt 34.9m
Long Term Debt 151.7m
Other Liabilities 391.2m

Wall St
Price Targets

MPL Price Targets Summary
Medibank Private Ltd

Wall Street analysts forecast MPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MPL is 4.09 AUD with a low forecast of 3.48 AUD and a high forecast of 4.78 AUD.

Lowest
Price Target
3.48 AUD
6% Downside
Average
Price Target
4.09 AUD
11% Upside
Highest
Price Target
4.78 AUD
29% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MPL?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MPL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest

Ownership

MPL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MPL News

Other Videos

Profile

Medibank Private Ltd Logo
Medibank Private Ltd

Country

Australia

Industry

Insurance

Market Cap

10.2B AUD

Dividend Yield

4.49%

Description

Medibank Private Ltd. engages in the underwriting and distribution of private health insurance policies through Medibank and ahm brands. The company is headquartered in Melbourne, Victoria and currently employs 3,409 full-time employees. The company went IPO on 2014-11-25. The firm operates through two segments: Health Insurance and Medibank Health. Health Insurance segment offers private health insurance products, including hospital cover and ancillary cover, as stand-alone products or packaged products that combine the two. Hospital cover provides members with health cover for hospital treatments, whereas ancillary cover provides members with health cover for healthcare services such as dental, optical and physiotherapy. The segment also offers health insurance products to overseas visitors and overseas students. Medibank Health segment is engaged in various activities, including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. In addition, it distributes travel, life and pet insurance products on behalf of other insurers. Medibank and ahm are its insurance policy brands.

Contact

VICTORIA
Melbourne
720 Bourke Street, Docklands
+61386225780.0
www.medibank.com.au

IPO

2014-11-25

Employees

3 409

Officers

CEO, MD & Director
Mr. David Koczkar B.Com., MAICD, PGDipFinance
Group Lead - Chief Financial Officer & Group Strategy
Mr. Mark Rogers B.Sc., BEng (Hons)
Group Chief Medical Officer
Dr. Andrew Wilson FACHSE, FRANZCP, M.M., MBBS
Group Lead - Chief Customer Officer
Mr. Milosh Milisavljevic
Group Lead ? Amplar Health
Mr. Robert Read B.A., BA(Psych), BComm(Mgt), GAICD
Group Lead ? Data & Technology
Ms. Felicia Trewin
Show More
Senior Executive of Investor Relations
Colette Campbell
Group Lead ? Trust, Legal, Group General Counsel & Company Secretary
Ms. Mei Ramsay B.A., L.L.B., L.L.M.
Group Lead - Chief Risk & Compliance Officer
Mr. Tom Exton
Senior Executive of External Affairs
Emily Ritchie
Show Less

See Also

Discover More
What is the Intrinsic Value of one MPL stock?

The intrinsic value of one MPL stock under the Base Case scenario is 3.99 AUD.

Is MPL stock undervalued or overvalued?

Compared to the current market price of 3.7 AUD, Medibank Private Ltd is Undervalued by 7%.

Back to Top